Cancer Immunotherapy Explained: PD-1, PD-L1, CTLA-4, Checkpoint Inhibitors and Immune Side Effects | Immune Checkpoint Inhibitors

Discover Immune Checkpoint Inhibitors with a focused overview of cancer immunotherapy, immune checkpoint inhibitors, and PD-1 PD-L1 blockade. The video outlines CTLA-4 inhibitors, immune related adverse events, and immuno-oncology, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for cancer immunotherapy, CTLA-4 inhibitors, or immune related adverse events and wanting a clearer explanation of how oncologists make treatment decisions. Relevant for anyone seeking clear, evidence-based context before discussing options with a multidisciplinary cancer team. Treatment plans vary with stage pathology molecular features prior therapy and patient fitness. Ask the treating